MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 12.11.2025
Adverum Biotechnologies P/S 2011-2026 | ADVM
P/S Jährlich Adverum Biotechnologies
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 76.4 | 4.96 | - | 23 | - | 2.66 K | 115 | 188 | 71 | 66.9 | 1.58 K | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.66 K | 4.96 | 532 |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M |  Germany |
 |
Alector
ALEC
|
11.7 | $ 2.11 | -13.17 % | $ 217 M |  USA |
 |
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | USA |
 |
Axsome Therapeutics
AXSM
|
13.6 | $ 163.89 | - | $ 8.15 B | USA |
 |
BridgeBio Pharma
BBIO
|
26.1 | $ 64.28 | -3.31 % | $ 12.3 B | USA |
 |
I-Mab
IMAB
|
94.1 | - | - | $ 866 M |  China |
 |
BioCardia
BCDA
|
18.6 | $ 1.37 | 5.81 % | $ 29 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | USA |
 |
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M |  Britain |
 |
BioMarin Pharmaceutical
BMRN
|
3.63 | $ 59.8 | -3.13 % | $ 11.5 B | USA |
 |
Bristol-Myers Squibb Company
BMY
|
2.54 | $ 62.08 | -0.46 % | $ 126 B | USA |
 |
Benitec Biopharma
BNTC
|
54.5 | $ 10.93 | 0.23 % | $ 450 M | USA |
 |
BioNTech SE
BNTX
|
35.7 | $ 109.33 | -0.82 % | $ 27.2 B | Germany |
 |
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | USA |
 |
BioXcel Therapeutics
BTAI
|
2.37 | $ 1.63 | -2.4 % | $ 4.13 M | USA |
 |
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M |  Canada |
 |
Burford Capital Limited
BUR
|
6.35 | $ 8.65 | 2.49 % | $ 1.39 B | Britain |
 |
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - |  Russia |
 |
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | USA |
 |
BeyondSpring
BYSI
|
69.6 | $ 1.34 | -0.87 % | $ 54 M | USA |
 |
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | USA |
 |
Cabaletta Bio
CABA
|
50.3 M | $ 3.34 | 0.61 % | $ 3.9 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 4.88 | 2.74 % | $ 10.6 B |  Israel |
 |
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | USA |
 |
Capricor Therapeutics
CAPR
|
6.17 | $ 27.28 | -2.32 % | $ 731 M | USA |
 |
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | Canada |
 |
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | USA |
 |
Catalyst Biosciences
CBIO
|
0.296 | $ 11.67 | -3.47 % | $ 768 M | USA |
 |
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | USA |
 |
C4 Therapeutics
CCCC
|
6.5 | $ 3.06 | 13.3 % | $ 254 M | USA |
 |
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | USA |
 |
Codexis
CDXS
|
4.91 | $ 0.99 | -2.04 % | $ 72.7 M | USA |
 |
Aridis Pharmaceuticals
ARDS
|
1.34 | - | 17.91 % | $ 11.1 M | USA |